Durbin, Cramer, Smith Applaud Inclusion Of Bill To Lower Cost Of Insulin For Patients In Year-End Funding Bill
December 21, 2019
December 21, 2019
WASHINGTON, Dec. 21 -- Sen. Richard J. Durbin, D-Illinois, issued the following news release:
U.S. Senators Dick Durbin (D-IL), Kevin Cramer (R-ND), and Tina Smith (D-MN) applauded the inclusion in the Fiscal Year (FY) 2020 appropriations bill of their Affordable Insulin Approvals Now Act, a bipartisan bill to speed up approvals of lower-cost, generic insulin products in order to help reduce prices of this life-saving medication for patients. Approximately 7.5 million Americans with . . .
U.S. Senators Dick Durbin (D-IL), Kevin Cramer (R-ND), and Tina Smith (D-MN) applauded the inclusion in the Fiscal Year (FY) 2020 appropriations bill of their Affordable Insulin Approvals Now Act, a bipartisan bill to speed up approvals of lower-cost, generic insulin products in order to help reduce prices of this life-saving medication for patients. Approximately 7.5 million Americans with . . .